Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-007548

Chief Scientific Officer sold 15,580 shares at an average $57.74 ($899,602)

  • Chief Scientific Officer acquired 15,580 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2021-02-01 Option exercise +7,790 $6.32 $49,233 8,469 D: show line 1 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-02-01 Sale −4,200 $55.54 $233,268 4,269 D: show line 2 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-02-01 Sale −3,590 $56.18 $201,686 679 D: show line 3 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-02-02 Option exercise +7,790 $6.32 $49,233 8,469 D: show line 4 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-02-02 Sale −2,910 $58.76 $170,992 5,559 D: show line 5 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-02-02 Sale −2,501 $59.80 $149,560 3,058 D: show line 6 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-02-02 Sale −2,379 $60.57 $144,096 679 D: show line 7 in the form
Open-market sales · 15,580 sh · avg $57.74 · $899,602

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2021-02-01 Option exercise · Stock Option (Right to Buy) −7,790 202,540 D: show line 8 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-02-02 Option exercise · Stock Option (Right to Buy) −7,790 194,750 D: show line 9 in the form
Loading xslF345X03/doc4.xml…